Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study
- 3 April 2023
- journal article
- research article
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30 (6) , 2607-2614
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imagingJournal of Nuclear Cardiology, 2021
- Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfallsJournal of Nuclear Cardiology, 2020
- Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT/CTJournal of Nuclear Cardiology, 2020
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imagingJournal of Nuclear Cardiology, 2019
- Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosisJournal of Nuclear Cardiology, 2019
- ASNC imaging guidelines for nuclear cardiology proceduresJournal of Nuclear Cardiology, 2017
- Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisCirculation, 2016